Literature DB >> 23591606

Trehangelins A, B and C, novel photo-oxidative hemolysis inhibitors produced by an endophytic actinomycete, Polymorphospora rubra K07-0510.

Takuji Nakashima1, Ryuki Okuyama, Yoshiyuki Kamiya, Atsuko Matsumoto, Masato Iwatsuki, Yuki Inahashi, Kenzaburo Yamaji, Yōko Takahashi, Satoshi Ōmura.   

Abstract

Three new natural products, designated trehangelins A, B and C, were isolated by solvent extraction, silica gel and octadecylsilyl silica gel column chromatographies and subsequent preparative HPLC from the cultured broth of an endophytic actinomycete strain, Polymorphospora rubra K07-0510. The trehangelins consisted of a trehalose moiety and two angelic acid moieties. Trehangelins A (IC50 value, 0.1 mg ml(-1)) and C (IC50 value, 0.4 mg ml(-1)), with symmetric structures, showed potent inhibitory activity against hemolysis of red blood cells induced by light-activated pheophorbide a. However, trehangelin B, with an asymmetric structure, displayed only a slight inhibition (IC50 value, 1.0 mg ml(-1)).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591606     DOI: 10.1038/ja.2013.17

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.

Authors:  Meeta Masand; Polpass Arul Jose; Ekta Menghani; Solomon Robinson David Jebakumar
Journal:  World J Microbiol Biotechnol       Date:  2015-09-26       Impact factor: 3.312

2.  New steroidal compounds from an actinomycete strain, Lechevalieria aerocolonigenes K10-0216.

Authors:  Takuji Nakashima; Yoshiyuki Kamiya; Kenzaburo Yamaji; Masato Iwatsuki; Noriko Sato; Yōko Takahashi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2014-12-10       Impact factor: 2.649

3.  Iminimycin A, the new iminium metabolite produced by Streptomyces griseus OS-3601.

Authors:  Takuji Nakashima; Rei Miyano; Masato Iwatsuki; Tatsuya Shirahata; Toru Kimura; Yukihiro Asami; Yoshinori Kobayashi; Kazuro Shiomi; George A Petersson; Yōko Takahashi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

4.  Anti-trypanosomal compound, sagamilactam, a new polyene macrocyclic lactam from Actinomadura sp. K13-0306.

Authors:  Tōru Kimura; Masato Iwatsuki; Yukihiro Asami; Aki Ishiyama; Rei Hokari; Kazuhiko Otoguro; Atsuko Matsumoto; Noriko Sato; Kazuro Shiomi; Yōko Takahashi; Satoshi Ōmura; Takuji Nakashima
Journal:  J Antibiot (Tokyo)       Date:  2016-03-30       Impact factor: 2.649

5.  Biosynthesis of angelyl-CoA in Saccharomyces cerevisiae.

Authors:  Roberta Callari; David Fischer; Harald Heider; Nora Weber
Journal:  Microb Cell Fact       Date:  2018-05-12       Impact factor: 5.328

6.  Potential of rare actinomycetes in the production of metabolites against multiple oxidant agents.

Authors:  Fatemeh Mohammadipanah; Mana Momenilandi
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

Review 7.  Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics.

Authors:  Yōko Takahashi; Takuji Nakashima
Journal:  Antibiotics (Basel)       Date:  2018-05-24

8.  Trehangelins ameliorate inflammation-induced skin senescence by suppressing the epidermal YAP-CCN1 axis.

Authors:  Mami Yokota; Yoshiyuki Kamiya; Tamie Suzuki; Shinsuke Ishikawa; Akira Takeda; Shinya Kondo; Takeshi Tohgasaki; Takuji Nakashima; Yoko Takahashi; Satoshi Ōmura; Tetsuhito Sakurai
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.